4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid has been researched along with tretinoin in 4 studies
| Studies (4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid) | Trials (4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid) | Recent Studies (post-2010) (4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid) | Studies (tretinoin) | Trials (tretinoin) | Recent Studies (post-2010) (tretinoin) |
|---|---|---|---|---|---|
| 14 | 0 | 0 | 23,654 | 1,083 | 6,085 |
| Protein | Taxonomy | 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid (IC50) | tretinoin (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 10 | |
| Amyloid-beta precursor protein | Homo sapiens (human) | 0.18 | |
| Adenosine receptor A3 | Homo sapiens (human) | 5.275 | |
| Retinoic acid receptor alpha | Homo sapiens (human) | 2.2542 | |
| 60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 5.3 | |
| Retinoic acid receptor beta | Homo sapiens (human) | 0.7537 | |
| Retinoic acid receptor alpha | Mus musculus (house mouse) | 0.0057 | |
| Retinoic acid receptor gamma | Homo sapiens (human) | 0.0064 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 5.275 | |
| Retinoic acid receptor gamma | Mus musculus (house mouse) | 0.004 | |
| Retinoic acid receptor beta | Mus musculus (house mouse) | 0.005 | |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 0.576 | |
| Nuclear receptor ROR-alpha | Homo sapiens (human) | 0.1995 | |
| Alpha-synuclein | Homo sapiens (human) | 3 | |
| Cellular retinoic acid-binding protein 1 | Gallus gallus (chicken) | 0.5233 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.358 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 5.275 | |
| Retinoic acid receptor RXR-gamma | Homo sapiens (human) | 0.35 | |
| Nuclear receptor ROR-gamma | Homo sapiens (human) | 0.1995 | |
| 10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 5.3 | |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | 0.82 | |
| 60 kDa chaperonin | Escherichia coli | 6.7 | |
| 10 kDa chaperonin | Escherichia coli | 6.7 | |
| Nuclear receptor ROR-beta | Homo sapiens (human) | 0.1259 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, WR; Dawson, MI; Derdzinski, KA; Frenking, G; Hobbs, PD; Jetten, AM; Loew, GH; Napoli, JL; Sani, BP; Williams, JB | 1 |
| Bernardon, JM; Charpentier, B; Eustache, J; Martin, B; Michel, S; Millois, C; Shroot, B | 1 |
| Dallery, N; Dautrevaux, M; Formstecher, P; Grillier, I; Sablonnière, B | 1 |
| Blomhoff, HK; Blomhoff, R; Dawson, MI; Gandhi, U; Lømo, J; Natarajan, V; Smeland, EB; Ulven, S | 1 |
4 other study(ies) available for 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid and tretinoin
| Article | Year |
|---|---|
Effect of structural modifications in the C7-C11 region of the retinoid skeleton on biological activity in a series of aromatic retinoids.
Topics: Animals; Cells, Cultured; Chemical Phenomena; Chemistry; Chick Embryo; Male; Molecular Conformation; Rabbits; Retinoids; Spectrophotometry, Ultraviolet; Structure-Activity Relationship | 1989 |
Synthesis, structure-affinity relationships, and biological activities of ligands binding to retinoic acid receptor subtypes.
Topics: Animals; Cell Differentiation; Magnetic Resonance Spectroscopy; Mice; Receptors, Retinoic Acid; Recombinant Proteins; Retinoic Acid Receptor alpha; Retinoic Acid Receptor gamma; Retinoids; Structure-Activity Relationship; Teratocarcinoma; Tretinoin; Tumor Cells, Cultured | 1995 |
Physicochemical parameters affecting the charcoal adsorption assay for quantitative retinoid-binding measurement.
Topics: Adsorption; Buffers; Charcoal; Chemical Phenomena; Chemistry, Physical; Dextrans; Hydrogen-Ion Concentration; Kinetics; Receptors, Retinoic Acid; Retinoids; Sensitivity and Specificity; Suspensions; Tretinoin; Tritium | 1994 |
RAR-, not RXR, ligands inhibit cell activation and prevent apoptosis in B-lymphocytes.
Topics: Alitretinoin; Apoptosis; B-Lymphocytes; CD40 Antigens; CD40 Ligand; DNA; DNA-Binding Proteins; Gene Expression; Humans; Immunoglobulin M; Interleukin-4; Ligands; Lymphocyte Activation; Membrane Glycoproteins; Receptors, Retinoic Acid; Retinoid X Receptors; Retinoids; Transcription Factors; Transcription, Genetic; Transfection; Tretinoin | 1998 |